APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nanoemulsions

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).

There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.

Selected research

Market Analysis & Forecast

Global Nanoemulsions Market Analysis and Forecast 2026-2032

Report ID 174015640221 December 2025193 pages

Choose your research edition.

Industry ResearchNanoemulsions Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanoemulsions Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Nanoemulsions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanoemulsions Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanoemulsions Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).

There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.

Read the full market overview

In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.

USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.

In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.

Report Includes

This report presents an overview of global market for Nanoemulsions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nanoemulsions, also provides the revenue of main regions and countries. Of the upcoming market potential for Nanoemulsions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nanoemulsions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nanoemulsions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nanoemulsions revenue, projected growth trends, production technology, application and end-user industry.

Nanoemulsions Segment by Company

Allergan plc

AbbVie Inc.

AstraZeneca Inc.

Fresenius Kabi AG

Kaken Pharmaceutical

GlaxoSmithKline

Novartis AG

Sanofi

B. Braun Melsungen

Nanoemulsions Segment by Type

Steroids

Anesthetics

NSAIDs

Immunosuppressant

Antiretroviral

Antimicrobials

Vasodilators

Others

Nanoemulsions Segment by Application

Pharmaceutical Industrial

Cosmetic Industrial

Food Industrial

Others

Nanoemulsions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanoemulsions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanoemulsions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanoemulsions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nanoemulsions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nanoemulsions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanoemulsions revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nanoemulsions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Steroids Major Player Table 3. Anesthetics Major Player Table 4. NSAIDs Major Player Table 5. Immunosuppressant Major Player Table 6. Antiretroviral Major Player Table 7. Antimicrobials Major Player Table 8. Vasodilators Major Player Table 9. Others Major Player Table 10. Global Nanoemulsions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Pharmaceutical Industrial Major Player Table 12. Cosmetic Industrial Major Player Table 13. Food Industrial Major Player Table 14. Others Major Player Table 15. Nanoemulsions Industry Trends Table 16. Nanoemulsions Industry Drivers Table 17. Nanoemulsions Industry Opportunities and Challenges Table 18. Nanoemulsions Industry Restraints Table 19. Global Nanoemulsions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global Nanoemulsions Market Size by Region (2021-2026) & (US$ Million) Table 21. Global Nanoemulsions Market Share by Region (2021-2026) Table 22. Global Nanoemulsions Market Size by Region (2027-2032) & (US$ Million) Table 23. Global Nanoemulsions Market Share by Region (2027-2032) Table 24. Global Nanoemulsions Revenue by Players (US$ Million) & (2021-2026) Table 25. Global Nanoemulsions Revenue Market Share by Players (2021-2026) Table 26. Global Nanoemulsions Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global Nanoemulsions Key Players Headquarters & Area Served Table 28. Global Nanoemulsions Players, Product Type & Application Table 29. Global Nanoemulsions Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global Nanoemulsions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Nanoemulsions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Nanoemulsions Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Nanoemulsions Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Nanoemulsions Revenue Market Share by Type (2021-2026) Table 36. Global Nanoemulsions Revenue Market Share by Type (2027-2032) Table 37. Global Nanoemulsions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nanoemulsions Revenue by Application (2021-2026) & (US$ Million) Table 39. Global Nanoemulsions Revenue by Application (2027-2032) & (US$ Million) Table 40. Global Nanoemulsions Revenue Market Share by Application (2021-2026) Table 41. Global Nanoemulsions Revenue Market Share by Application (2027-2032) Table 42. Allergan plc Company Information Table 43. Allergan plc Business Overview Table 44. Allergan plc Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Allergan plc Nanoemulsions Product Portfolio Table 46. Allergan plc Recent Development Table 47. AbbVie Inc. Company Information Table 48. AbbVie Inc. Business Overview Table 49. AbbVie Inc. Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. AbbVie Inc. Nanoemulsions Product Portfolio Table 51. AbbVie Inc. Recent Development Table 52. AstraZeneca Inc. Company Information Table 53. AstraZeneca Inc. Business Overview Table 54. AstraZeneca Inc. Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. AstraZeneca Inc. Nanoemulsions Product Portfolio Table 56. AstraZeneca Inc. Recent Development Table 57. Fresenius Kabi AG Company Information Table 58. Fresenius Kabi AG Business Overview Table 59. Fresenius Kabi AG Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Fresenius Kabi AG Nanoemulsions Product Portfolio Table 61. Fresenius Kabi AG Recent Development Table 62. Kaken Pharmaceutical Company Information Table 63. Kaken Pharmaceutical Business Overview Table 64. Kaken Pharmaceutical Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Kaken Pharmaceutical Nanoemulsions Product Portfolio Table 66. Kaken Pharmaceutical Recent Development Table 67. GlaxoSmithKline Company Information Table 68. GlaxoSmithKline Business Overview Table 69. GlaxoSmithKline Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. GlaxoSmithKline Nanoemulsions Product Portfolio Table 71. GlaxoSmithKline Recent Development Table 72. Novartis AG Company Information Table 73. Novartis AG Business Overview Table 74. Novartis AG Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Novartis AG Nanoemulsions Product Portfolio Table 76. Novartis AG Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Sanofi Nanoemulsions Product Portfolio Table 81. Sanofi Recent Development Table 82. B. Braun Melsungen Company Information Table 83. B. Braun Melsungen Business Overview Table 84. B. Braun Melsungen Nanoemulsions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. B. Braun Melsungen Nanoemulsions Product Portfolio Table 86. B. Braun Melsungen Recent Development Table 87. North America Nanoemulsions Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Nanoemulsions Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Nanoemulsions Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Nanoemulsions Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Nanoemulsions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Nanoemulsions Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Nanoemulsions Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Nanoemulsions Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Nanoemulsions Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Nanoemulsions Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Nanoemulsions Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Nanoemulsions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Nanoemulsions Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Nanoemulsions Revenue by Country (US$ Million) & (2027-2032) Table 101. China Nanoemulsions Revenue by Type (2021-2026) & (US$ Million) Table 102. China Nanoemulsions Revenue by Type (2027-2032) & (US$ Million) Table 103. China Nanoemulsions Revenue by Application (2021-2026) & (US$ Million) Table 104. China Nanoemulsions Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Nanoemulsions Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Nanoemulsions Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Nanoemulsions Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Nanoemulsions Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Nanoemulsions Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Nanoemulsions Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Nanoemulsions Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Nanoemulsions Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Nanoemulsions Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Nanoemulsions Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Nanoemulsions Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Nanoemulsions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Nanoemulsions Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Nanoemulsions Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Nanoemulsions Image Figure 2. Global Nanoemulsions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanoemulsions Market Size Share 2021 VS 2025 VS 2032 Figure 4. Steroids Image Figure 5. Anesthetics Image Figure 6. NSAIDs Image Figure 7. Immunosuppressant Image Figure 8. Antiretroviral Image Figure 9. Antimicrobials Image Figure 10. Vasodilators Image Figure 11. Others Image Figure 12. Global Nanoemulsions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nanoemulsions Market Size Share 2021 VS 2025 VS 2032 Figure 14. Pharmaceutical Industrial Image Figure 15. Cosmetic Industrial Image Figure 16. Food Industrial Image Figure 17. Others Image Figure 18. Global Nanoemulsions Market Size (US$ Million) & (2021-2032) Figure 19. Global Nanoemulsions Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Nanoemulsions Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Nanoemulsions Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Nanoemulsions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nanoemulsions Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Nanoemulsions Revenue Market Share by Type (2021-2032) Figure 26. Global Nanoemulsions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Nanoemulsions Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global Nanoemulsions Revenue Market Share by Application (2021-2032) Figure 29. North America Nanoemulsions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Nanoemulsions Revenue Share by Type (2021-2032) Figure 31. North America Nanoemulsions Revenue Share by Application (2021-2032) Figure 32. North America Nanoemulsions Revenue Share by Country (2021-2032) Figure 33. United States Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe Nanoemulsions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Nanoemulsions Revenue Share by Type (2021-2032) Figure 38. Europe Nanoemulsions Revenue Share by Application (2021-2032) Figure 39. Europe Nanoemulsions Revenue Share by Country (2021-2032) Figure 40. Germany Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China Nanoemulsions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China Nanoemulsions Revenue Share by Type (2021-2032) Figure 50. China Nanoemulsions Revenue Share by Application (2021-2032) Figure 51. Asia Nanoemulsions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia Nanoemulsions Revenue Share by Type (2021-2032) Figure 53. Asia Nanoemulsions Revenue Share by Application (2021-2032) Figure 54. Asia Nanoemulsions Revenue Share by Region (2021-2032) Figure 55. Japan Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA Nanoemulsions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA Nanoemulsions Revenue Share by Type (2021-2032) Figure 63. SAMEA Nanoemulsions Revenue Share by Application (2021-2032) Figure 64. SAMEA Nanoemulsions Revenue Share by Country (2021-2032) Figure 65. Brazil Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt Nanoemulsions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Steroids
  • Anesthetics
  • NSAIDs
  • Immunosuppressant
  • Antiretroviral
  • Antimicrobials
  • Vasodilators
  • Others
Applications
  • Pharmaceutical Industrial
  • Cosmetic Industrial
  • Food Industrial
  • Others
Companies covered
  • Allergan plc
  • AbbVie Inc.
  • AstraZeneca Inc.
  • Fresenius Kabi AG
  • Kaken Pharmaceutical
  • GlaxoSmithKline
  • Novartis AG
  • Sanofi
  • B. Braun Melsungen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nanoemulsions Market by Type
  3. 1.2.1 Global Nanoemulsions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Steroids
  5. 1.2.3 Anesthetics
  6. 1.2.4 NSAIDs
  7. 1.2.5 Immunosuppressant
  8. 1.2.6 Antiretroviral
  9. 1.2.7 Antimicrobials
  10. 1.2.8 Vasodilators
  11. 1.2.9 Others
  12. 1.3 Nanoemulsions Market by Application
  13. 1.3.1 Global Nanoemulsions Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Pharmaceutical Industrial
  15. 1.3.3 Cosmetic Industrial
  16. 1.3.4 Food Industrial
  17. 1.3.5 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Nanoemulsions Market Dynamics
  1. 2.1 Nanoemulsions Industry Trends
  2. 2.2 Nanoemulsions Industry Drivers
  3. 2.3 Nanoemulsions Industry Opportunities and Challenges
  4. 2.4 Nanoemulsions Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nanoemulsions Market Perspective (2021-2032)
  2. 3.2 Global Nanoemulsions Growth Trends by Region
  3. 3.2.1 Global Nanoemulsions Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nanoemulsions Market Size by Region (2021-2026)
  5. 3.2.3 Global Nanoemulsions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nanoemulsions Revenue by Players
  2. 4.1.1 Global Nanoemulsions Revenue by Players (2021-2026)
  3. 4.1.2 Global Nanoemulsions Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nanoemulsions Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nanoemulsions Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nanoemulsions Key Players Headquarters & Area Served
  7. 4.4 Global Nanoemulsions Players, Product Type & Application
  8. 4.5 Global Nanoemulsions Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nanoemulsions Market CR5 and HHI
  11. 4.6.3 2025 Nanoemulsions Tier 1, Tier 2, and Tier 3
5 Nanoemulsions Market Size by Type
  1. 5.1 Global Nanoemulsions Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nanoemulsions Revenue by Type (2021-2032)
  3. 5.3 Global Nanoemulsions Revenue Market Share by Type (2021-2032)
6 Nanoemulsions Market Size by Application
  1. 6.1 Global Nanoemulsions Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nanoemulsions Revenue by Application (2021-2032)
  3. 6.3 Global Nanoemulsions Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Allergan plc
  2. 7.1.1 Allergan plc Company Information
  3. 7.1.2 Allergan plc Business Overview
  4. 7.1.3 Allergan plc Nanoemulsions Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Allergan plc Nanoemulsions Product Portfolio
  6. 7.1.5 Allergan plc Recent Developments
  7. 7.2 AbbVie Inc.
  8. 7.2.1 AbbVie Inc. Company Information
  9. 7.2.2 AbbVie Inc. Business Overview
  10. 7.2.3 AbbVie Inc. Nanoemulsions Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AbbVie Inc. Nanoemulsions Product Portfolio
  12. 7.2.5 AbbVie Inc. Recent Developments
  13. 7.3 AstraZeneca Inc.
  14. 7.3.1 AstraZeneca Inc. Company Information
  15. 7.3.2 AstraZeneca Inc. Business Overview
  16. 7.3.3 AstraZeneca Inc. Nanoemulsions Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca Inc. Nanoemulsions Product Portfolio
  18. 7.3.5 AstraZeneca Inc. Recent Developments
  19. 7.4 Fresenius Kabi AG
  20. 7.4.1 Fresenius Kabi AG Company Information
  21. 7.4.2 Fresenius Kabi AG Business Overview
  22. 7.4.3 Fresenius Kabi AG Nanoemulsions Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Fresenius Kabi AG Nanoemulsions Product Portfolio
  24. 7.4.5 Fresenius Kabi AG Recent Developments
  25. 7.5 Kaken Pharmaceutical
  26. 7.5.1 Kaken Pharmaceutical Company Information
  27. 7.5.2 Kaken Pharmaceutical Business Overview
  28. 7.5.3 Kaken Pharmaceutical Nanoemulsions Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Kaken Pharmaceutical Nanoemulsions Product Portfolio
  30. 7.5.5 Kaken Pharmaceutical Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Nanoemulsions Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Nanoemulsions Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 Novartis AG
  38. 7.7.1 Novartis AG Company Information
  39. 7.7.2 Novartis AG Business Overview
  40. 7.7.3 Novartis AG Nanoemulsions Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Novartis AG Nanoemulsions Product Portfolio
  42. 7.7.5 Novartis AG Recent Developments
  43. 7.8 Sanofi
  44. 7.8.1 Sanofi Company Information
  45. 7.8.2 Sanofi Business Overview
  46. 7.8.3 Sanofi Nanoemulsions Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Nanoemulsions Product Portfolio
  48. 7.8.5 Sanofi Recent Developments
  49. 7.9 B. Braun Melsungen
  50. 7.9.1 B. Braun Melsungen Company Information
  51. 7.9.2 B. Braun Melsungen Business Overview
  52. 7.9.3 B. Braun Melsungen Nanoemulsions Revenue and Gross Margin (2021-2026)
  53. 7.9.4 B. Braun Melsungen Nanoemulsions Product Portfolio
  54. 7.9.5 B. Braun Melsungen Recent Developments
8 North America
  1. 8.1 North America Nanoemulsions Revenue (2021-2032)
  2. 8.2 North America Nanoemulsions Revenue by Type (2021-2032)
  3. 8.2.1 North America Nanoemulsions Revenue by Type (2021-2026)
  4. 8.2.2 North America Nanoemulsions Revenue by Type (2027-2032)
  5. 8.3 North America Nanoemulsions Revenue Share by Type (2021-2032)
  6. 8.4 North America Nanoemulsions Revenue by Application (2021-2032)
  7. 8.4.1 North America Nanoemulsions Revenue by Application (2021-2026)
  8. 8.4.2 North America Nanoemulsions Revenue by Application (2027-2032)
  9. 8.5 North America Nanoemulsions Revenue Share by Application (2021-2032)
  10. 8.6 North America Nanoemulsions Revenue by Country
  11. 8.6.1 North America Nanoemulsions Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nanoemulsions Revenue by Country (2021-2026)
  13. 8.6.3 North America Nanoemulsions Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nanoemulsions Revenue (2021-2032)
  2. 9.2 Europe Nanoemulsions Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nanoemulsions Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nanoemulsions Revenue by Type (2027-2032)
  5. 9.3 Europe Nanoemulsions Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nanoemulsions Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nanoemulsions Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nanoemulsions Revenue by Application (2027-2032)
  9. 9.5 Europe Nanoemulsions Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nanoemulsions Revenue by Country
  11. 9.6.1 Europe Nanoemulsions Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nanoemulsions Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nanoemulsions Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nanoemulsions Revenue (2021-2032)
  2. 10.2 China Nanoemulsions Revenue by Type (2021-2032)
  3. 10.2.1 China Nanoemulsions Revenue by Type (2021-2026)
  4. 10.2.2 China Nanoemulsions Revenue by Type (2027-2032)
  5. 10.3 China Nanoemulsions Revenue Share by Type (2021-2032)
  6. 10.4 China Nanoemulsions Revenue by Application (2021-2032)
  7. 10.4.1 China Nanoemulsions Revenue by Application (2021-2026)
  8. 10.4.2 China Nanoemulsions Revenue by Application (2027-2032)
  9. 10.5 China Nanoemulsions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nanoemulsions Revenue (2021-2032)
  2. 11.2 Asia Nanoemulsions Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nanoemulsions Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nanoemulsions Revenue by Type (2027-2032)
  5. 11.3 Asia Nanoemulsions Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nanoemulsions Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nanoemulsions Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nanoemulsions Revenue by Application (2027-2032)
  9. 11.5 Asia Nanoemulsions Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nanoemulsions Revenue by Country
  11. 11.6.1 Asia Nanoemulsions Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nanoemulsions Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nanoemulsions Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nanoemulsions Revenue (2021-2032)
  2. 12.2 SAMEA Nanoemulsions Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nanoemulsions Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nanoemulsions Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nanoemulsions Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nanoemulsions Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nanoemulsions Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nanoemulsions Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nanoemulsions Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nanoemulsions Revenue by Country
  11. 12.6.1 SAMEA Nanoemulsions Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nanoemulsions Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nanoemulsions Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst